• Home
  • Clinical Topics
    • Cardiovascular Disease
    • Diabetes
    • Hematology
    • Infectious disease
    • Mental health / PTSD
    • Neurology
    • Oncology
    • Orthopedics
    • Pain management
    • Pulmonology
    • Rheumatology
    • Women’s health
  • Non-Clinical Topics
    • Legislation
    • Personnel
    • Policy
    • Research
    • Pharmacy Update
    • Technology
  • Special Issues
    • 2026 Compendium of Federal Medicine
    • Advances in Treatment for Serious Clinical Depression in the Military and Va
    • Evolving Therapies at VA Improve Colorectal Cancer Survival
    • Advances in Use of Therapy Combinations for Recurrent Relapsed Multiple Myeloma at VA
    • 2026 USM Directory
    • Advances in Wound Care
    • Operationalization of Bispecific Therapy Supplement
  • Departments
    • Department of Veterans Affairs (VA)
    • Military Health System
    • Public Health Service
  • Opinion
  • Subscription
    • Print Subscription
    • e-Newsletter Subscription
  • Contact Us

New Ferritin Thresholds Recommended in Guidelines Have Benefits, Disadvantages

by U.S. Medicine | Oct 6, 2026

Clinical management guidelines from the American Gastroenterological Association (AGA) in 2020 sought to standardize iron deficiency anemia (IDA) management.

New Ferritin Thresholds Recommended in Guidelines Have Benefits, Disadvantages

by U.S. Medicine | Sep 9, 2026

Clinical management guidelines from the American Gastroenterological Association (AGA) in 2020 sought to standardize iron deficiency anemia (IDA) management.

End-stage Renal Disease, Patients Treated for Rare Blood Disorder at Lower Risk of Mortality

by LaTina Emerson | Dec 10, 2025

Patients with end-stage renal disease (ESRD) with thrombotic thrombocytopenic purpura (TTP) who are treated by therapeutic plasma exchange (TPE) are at lower risk of mortality than ESRD patients without this diagnosis. That indicated that TPE is warranted when there is clinical suspicion of TTP, according to a recent study.

Debate Continues on Whether Antithrombotics Increase Fall Risk for Older Adults

by Brenda Mooney | Nov 14, 2025

Antiplatelet and anticoagulant medications often are prescribed for older adults who suffer atherosclerotic and thromboembolic disease.

Hypocalcemia Resulting From Blood Transfusions for Traumatic Injury

by Brenda Mooney | Sep 16, 2025

The leading cause of death after trauma is hemorrhage, which usually can be managed by blood transfusions.

Extracellular Matrix Proteins Linked With Abdominal Aortic Aneurysm

by U.S. Medicine | Aug 20, 2025

Genetic studies have identified numerous risk loci, many potentially encoding plasma proteins, for abdominal aortic aneurysm (AAA).

Erythropoietin Stimulating Agents Could Offer Hope for Trauma Patients

by Mary Anne Dunkin | Aug 20, 2025

Erythropoietin stimulating agents (ESAs) have long played an essential role in the treatment for chronic anemia.

Gulf War Veterans Could Face Future Risk of Clonal Hematopoiesis

Gulf War Veterans Could Face Future Risk of Clonal Hematopoiesis

by Brenda Mooney | Jul 15, 2025

Clonal hematopoiesis (CH) is a precursor to myeloid neoplasms (MN) and could be an indicator of clinically significant toxin exposure by military servicemembers, according to a pilot study.

Hypocalcemia Resulting From Blood Transfusions for Traumatic Injury

by U.S. Medicine | Jun 13, 2025

The leading cause of death after trauma is hemorrhage, which usually can be managed by blood transfusions.

Anemia From Menstruation Abnormalities Linked to Stroke

by U.S. Medicine | Jun 13, 2025

Even though, in recent years, stroke incidence in older adults has declined significantly, it appears to be on the rise in younger women.

Hypercortisolism: A Hidden Factor in Difficult-to-Control Type 2 Diabetes

by Mary Anne Dunkin | Jun 13, 2025

Despite the growing arsenal of glucose-lowering medications, many patients with Type 2 diabetes still struggle to achieve adequate blood glucose control.

Bridging the Gap: Treating Myeloproliferative Neoplasms in U.S. Veterans

by Annette Boyle | May 26, 2025

A disconnect persists between patient and physician expectations for treatment of myeloproliferative neoplasms (MPNs), particularly in managing symptom burden and quality of life.

Study: Propofol Use Should Be Minimized in Children With ALL

by U.S. Medicine | Sep 15, 2024

A study involving military researchers has raised concerns about the use of certain types of anesthesia in children with acute lymphocytic leukemia (ALL)

Circumstances Linked to Bleeding Risk With Chronic Liver Disease Diagnosis

by U.S. Medicine | Sep 15, 2024

A recent study looked at risk factors for non-variceal bleeding within the first year after diagnosis of chronic liver disease in veterans.

Multiple Myeloma Patients Have Longer Survival With Military Healthcare

by U.S. Medicine | Sep 15, 2024

MHS beneficiaries with multiple myeloma (MM) had improved overall survival compared to MM patients from the U.S. general population, according to a new report.

More Than 14 million U.S. Adults on Statins Might Not Really Need Them

by Brenda Mooney | Jul 9, 2024

Equations that estimate 10-year risk of atherosclerotic cardiovascular disease (ASCVD) appear to have overestimated the number of U.S. adults eligible for primary prevention statin therapy, according to a new study.

Iron Deficiency Independently Association With Heart Failure Development

by U.S. Medicine | Jun 11, 2024

What is the relationship of iron status with incident heart failure in community-dwelling older adults, without regard to their kidney function?

Propofol Is Impairment Risk Factor in Children With ALL

by U.S. Medicine | Jun 11, 2024

New research evaluated the effect of cumulative exposure to anesthesia on neurocognitive outcomes among a multicenter cohort of children with acute lymphocytic leukemia (ALL).

Almost 1 in 11 U.S. Military Casualties Received Warm Fresh Whole Blood

by U.S. Medicine | Jun 11, 2024

To help save lives, especially in battlefield situations, the U.S. military has frequently used a so-called walking blood bank to obtain warm, fresh whole blood (WFWB).

Study Emphasizes Importance of β-cell Function Loss in T2D Progression

by Mary Anne Dunkin | Jun 11, 2024

For the estimated 1 in 10 Americans—or 1 in 4 veterans—with Type 2 diabetes, keeping blood glucose levels in the near-normal range reduces the risk of complications such as heart, kidney and eye disease.

Reducing the Number of PPI Prescriptions: Benefits and Potential Pitfalls

by Mary Anne Dunkin | Jun 10, 2024

One of the most commonly prescribed classes of drugs, proton pump inhibitors (PPIs), reduces the risk of gastrointestinal bleeding in certain patients at increased risk. Most PPI prescriptions are written for other reasons, however. In fact, an estimated 25-70% of PPI users might not have an appropriate indication.

New Study Defines Clinically Important Measures of Diabetes Distress

by LaTina Emerson | Mar 12, 2024

The term “diabetes distress” is used to describe the emotional response to living with diabetes, a life-threatening illness that requires chronic and demanding self-management.

No Racial Differences in DLBCL Treatment Within VA Healthcare System

by U.S. Medicine | Dec 13, 2023

No statistically significant racial differences in diffuse large B-cell lymphoma (DLBCL) outcomes were found for patients treated within the VHA, according to recent research.

Very Elderly Patients Fare Much Worse When Treated for DLBCL

by U.S. Medicine | Dec 13, 2023

Diffuse large B-cell lymphoma (DLBCL) becomes much more difficult to treat in older patients, according to a new study suggesting that more adults of advanced age be included in clinical trials for new agents.

Despite Disparities, Making a Difference for Veterans With Relapsed DLBCL

by U.S. Medicine | Dec 13, 2023

DURHAM, NC—Recent Food and Drug Administration approvals of chimeric antigen receptor (CAR) T cell therapies and novel immunotherapies have helped to significantly improve outcomes for patients with relapsed and refractory diffuse large B cell lymphoma (R/R DLBCL)....

More Diverse Dataset Raises Questions about MGUS Risk Models

by U.S. Medicine | Dec 9, 2023

Patients with monoclonal gammopathy of undetermined significance (MGUS) have been thought to have a less than 1% chance of progressing to multiple myeloma as long as their M-protein levels are below 1.5 g/dL.

For CLL, BTK Inhibitors Appear to Extend Time to Next Line Most

by U.S. Medicine | Dec 9, 2023

JACKSONVILLE, FL—As treatment options for chronic lymphocytic leukemia (CLL) multiply, physicians face an increasing array of sequencing options but have little guidance from clinical trials of the most effective order given each patient’s specific disease...

Gulf War Illness Reduces White Blood Cells’ Ability to Make Energy

by Brenda Mooney | Dec 6, 2023

The ability of white blood cells to make energy is significantly reduced in Gulf War Illness (GWI), which affects approximately 250,000 U.S. veterans, according to a new study finding a measurable biochemical difference in veterans who have the disease.

CRC Screening Levels Too Low for Veterans With Anemia, Hematochezia

by Brenda Mooney | Dec 6, 2023

Already the second-leading cause of cancer death in the United States, colorectal cancer (CRC) is increasing in adults younger than 50. Early-age onset CRC (EAOCRC) is often diagnosed at later stages, which require more intense treatment, according to a new study.

MGUS Higher in Servicemembers, No Association Seen With Burn Pit Exposure

by U.S. Medicine | Dec 9, 2023

Individuals who have served in the U.S. military have about three times the risk of monoclonal gammopathy of undetermined significance (MGUS) as a similarly aged cohort in the Icelandic iStopMM study.

Subscribe to the print edition of U.S. Medicine

U.S. Medicine is mailed free each month to physicians, pharmacists, nurse practitioners, physician assistants and administrators working for Veterans Affairs, Department of Defense and Indian Health Service.

Subscribe Now

Sign up to receive the U.S. Medicine e-Newsletter

Stay informed about federal medical news, clinical updates and reports on government topics for the federal healthcare professional.

 Sign Up

  • For Advertisers
  • e-Newsletter
  • Subscribe to U.S. Medicine Print Publication
  • About Us
  • Privacy Policy
  • Do Not Sell or Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use